Katie (Colby) Dahlstrom
About Katie (Colby) Dahlstrom
Katie (Colby) Dahlstrom is the Senior Director of Clinical Operations at Agios Pharmaceuticals, with a background in clinical research and safety surveillance.
Current Role at Agios Pharmaceuticals
Katie Dahlstrom currently holds the position of Senior Director, Clinical Operations at Agios Pharmaceuticals. She has been in this role since 2019, contributing to the company's clinical operations in Cambridge, Massachusetts. Her responsibilities include overseeing clinical trials and ensuring compliance with regulatory standards.
Previous Experience at Agios Pharmaceuticals
Before her current role, Katie Dahlstrom served as Senior Director, Clinical Operations at Agios Pharmaceuticals from 2018 to 2019. During this time, she focused on enhancing clinical development strategies and improving operational efficiencies within the organization.
Education and Academic Background
Katie Dahlstrom studied at Boston University School of Medicine, where she earned a Master of Arts degree from 2009 to 2011. Prior to this, she completed her Bachelor of Science degree at Stonehill College from 2004 to 2008. Additionally, she participated in an International Semester Abroad program at University College Cork in 2006.
Professional Experience in Clinical Research
Katie Dahlstrom has extensive experience in clinical research. She worked at Millennium Pharmaceuticals as a Clinical Research Coordinator from 2011 to 2013 and later as a Clinical Research Associate for a brief period in 2013. Additionally, she held positions at Sanofi Genzyme as a Safety Surveillance Scientist from 2010 to 2011 and as a Global Patient Safety Associate from 2008 to 2010.